JJX

Product Code: JJX


Products Classified as JJX

469Single (specified) Analyte Controls (assayed And Unassayed)Quality Control Material (assayed And Unassayed).

Total Product Life Cycle (TPLC) Devices

469Single (specified) Analyte Controls (assayed And Unassayed)Quality Control Material (assayed And Unassayed).

FDA Consensus Standards

Single (Specified) Analyte Controls (Assayed And Unassayed) [34731]21 CFR §862.1660 🔎

Pre-market Notifications for JJX

K170678Beta-CrossLaps CalCheck 5Roche Diagnostics
K162514Multichem A1cTechnopath Manufacturing
K162173Elecsys CYFRA 21-1 CalCheck 5Roche Diagnostics
K161874Audit MicroControls Linearity DROP LQ Blood GlucoseAALTO SCIENTIFIC, LTD.
K161526LIAISON CMV IgM Serum Control SetDiaSorin Inc.
K161522LIAISON EBV IgM Serum Control SetDiaSorin Inc.
K161082IDS-iSYS 17-OH Progesterone Control Set, IDS-iSYS 17-OH Progesterone Calibration VerifiersIMMUNODIAGNOSTIC SYSTEMS LTD.
K152117Dropper HsCRP High Sensitivity CRP ControlQuantimetrix Corporation
K151742Contour Next Control SolutionBAYER HEALTHCARE
K150955Elecsys Progesterone III Cal Check 5ROCHE DIAGNOSTICS
K150132IMMULITE IGF Control Module, IMMULITE Gastrin Control ModuleSiemens Healthcare Diagnostics
K143687ADVIA Centaur Follicle Stimulating Hormone (FSH) Master Curve Material, ADVIA Centaur FT4 Master Curve Material, ADVIA Centaur T4 Master Curve Material, ADVIA Centaur T3 Master Curve MaterialSIEMENS HEALTHCARE DIAGNOSTICS, INC.
K143680ADVIA Centaur IgE Master Curve MaterialSIEMENS HEALTHCARE DIAGNOSTICS, INC.
K143636IMMULITE 2000 Androstenedione Calibration Verification Material, IMMULITE 2000 Troponin I Calibration Verification MaterialSIEMENS HEALTHCARE DIAGNOSTICS, INC.
K143639IMMULITE 2000 CEA Calibration Verification MaterialSiemens Healthcare Diagnostics

Global Unique Device Identification Database

00389167262101Single (Specified) Analyte Controls (Assayed And Unassayed)
00389154000549Single (Specified) Analyte Controls (Assayed And Unassayed)
00389154000716Single (Specified) Analyte Controls (Assayed And Unassayed)
00389154000495Single (Specified) Analyte Controls (Assayed And Unassayed)
20385543764027Single (Specified) Analyte Controls (Assayed And Unassayed)
00385480547901Single (specified) analyte controls (assayed and unassayed)
00385480528559Single (specified) analyte controls (assayed and unassayed)
00385480475549Single (specified) analyte controls (assayed and unassayed)
00385480475532Single (specified) analyte controls (assayed and unassayed)
10385480467992Single (specified) analyte controls (assayed and unassayed)
10385480458860Single (specified) analyte controls (assayed and unassayed)
00385480440370Single (specified) analyte controls (assayed and unassayed)
00385480439237Single (specified) analyte controls (assayed and unassayed)
00385480439220Single (specified) analyte controls (assayed and unassayed)
00385480439213Single (specified) analyte controls (assayed and unassayed)

Maude Adverse Events

CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-23
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-18
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-18
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-18
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-16
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-03-04
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-02-24
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-02-07
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-02-06
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-02-04
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-02-04
BIOPLEX 2200BIO-RAD LABORATORIES, INC2020-02-04
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-01-22
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-01-15
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-01-13
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2020-01-03
CONTOURASCENSIA DIABETES CARE US INC.2020-01-03
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-12-17
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-12-06
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-11-25
ROM PLUS RUPTURE MEMBRANES TESTCLINICAL INNOVATIONS, LLC2019-11-21
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-11-21
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-11-20
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-11-20
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-11-15
ARCHITECT BNP CONTROLSABBOTT GERMANY2019-11-08
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-31
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-25
CONTOUR NEXT ONEASCENSIA DIABETES CARE US INC.2019-10-25
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-24
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-24
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-02
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-02
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-10-01
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-27
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-27
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-25
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-25
ARCHITECT BNP CONTROLSABBOTT GERMANY2019-09-20
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-02
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-02
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-09-02
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-08-23
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-08-12
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-08-09
ARCHITECT BNP CONTROLSABBOTT GERMANY2019-08-07
ARCHITECT BNP CONTROLSABBOTT GERMANY2019-08-07
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-08-01
ARCHITECT BNP CONTROLSABBOTT LABORATORIES2019-07-22
CONTOUR NEXTASCENSIA DIABETES CARE US INC.2019-07-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.